 |
|
|
   
|
LONG BEACH, CA (September 13, 2006) – Obagi Medical Products, Inc. (Obagi),
announced today that it has filed a registration statement with the U.S.
Securities and Exchange Commission relating to a proposed initial public
offering of shares of its common stock. The number of shares to be offered and
the price range for the offering have not yet been determined.
J.P. Morgan Securities Inc. will serve as sole book-running manager for the
offering, with CIBC World Markets Corp, Thomas Weisel Partners LLC and Robert W.
Baird & Co. Incorporated acting as co-managers. A preliminary prospectus, when
available, may be obtained from the offices of J.P. Morgan Securities Inc., 277
Park Avenue, New York , New York 10172.
A registration statement relating to these securities has been filed with the
U.S. Securities and Exchange Commission, but has not yet become effective.
Theses securities may not be sold nor may offers to buy be accepted prior to the
time the registration statement becomes effective. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction in which such
offer, solicitation or sales would be unlawful prior to registration or
qualification under the securities laws of any such state or jurisdiction.
|
|
|
|